Want to see CCM full AI Analyst Report?
Concord Medical Services (CCM) Ratios
108 Followers
Concord Medical Services Ratios
CCM's free cash flow for Q4 2025 was ¥0.00. For the 2025 fiscal year, CCM's free cash flow was increased by ¥0.00 and operating cash flow was ¥0.00. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.48 | 0.46 | 0.32 | 0.68 | 0.73 |
| Quick Ratio | 0.46 | 0.45 | 0.30 | 0.60 | 0.68 |
| Cash Ratio | 0.15 | 0.10 | 0.03 | 0.14 | 0.20 |
| Solvency Ratio | 0.01 | -0.03 | -0.04 | -0.09 | -0.05 |
| Operating Cash Flow Ratio | -0.10 | -0.19 | -0.14 | -0.19 | -0.45 |
| Short-Term Operating Cash Flow Coverage | -0.21 | -0.39 | -0.27 | -0.42 | -1.20 |
| Net Current Asset Value | ¥ -3.76B | ¥ -4.12B | ¥ -3.69B | ¥ -3.23B | ¥ -2.90B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.56 | 0.58 | 0.54 | 0.54 | 0.44 |
| Debt-to-Equity Ratio | -1.73 | -1.72 | -1.55 | -1.74 | -1.99 |
| Debt-to-Capital Ratio | 2.37 | 2.38 | 2.81 | 2.35 | 2.01 |
| Long-Term Debt-to-Capital Ratio | 6.50 | 6.26 | -18.66 | 3.97 | 2.65 |
| Financial Leverage Ratio | -3.11 | -2.95 | -2.85 | -3.22 | -4.55 |
| Debt Service Coverage Ratio | -0.07 | -0.27 | -0.26 | -0.52 | -0.96 |
| Interest Coverage Ratio | -1.57 | -2.75 | -2.79 | -4.36 | -6.21 |
| Debt to Market Cap | 882.00 | 655.27 | 257.18 | 182.40 | 408.22 |
| Interest Debt Per Share | 26009.06 | 28323.70 | 23773.15 | 23078.54 | 58265.31 |
| Net Debt to EBITDA | -46.50 | -10.75 | -9.41 | -7.67 | -7.08 |
| Profitability Margins | |||||
| Gross Profit Margin | 5.61% | -20.62% | -14.26% | -32.28% | -11.72% |
| EBIT Margin | -48.00% | -124.07% | -86.15% | -111.22% | -94.38% |
| EBITDA Margin | -15.59% | -90.02% | -64.04% | -85.12% | -74.92% |
| Operating Profit Margin | -51.97% | -138.60% | -86.15% | -111.22% | -94.38% |
| Pretax Profit Margin | -81.07% | -174.39% | -103.39% | -177.91% | -108.98% |
| Net Profit Margin | -20.15% | -80.28% | -55.39% | -103.72% | -55.89% |
| Continuous Operations Profit Margin | -82.39% | -169.83% | -98.81% | -162.89% | -107.63% |
| Net Income Per EBT | 24.86% | 46.04% | 53.57% | 58.30% | 51.29% |
| EBT Per EBIT | 156.00% | 125.82% | 120.00% | 159.97% | 115.47% |
| Return on Assets (ROA) | -1.42% | -4.58% | -4.92% | -8.15% | -4.36% |
| Return on Equity (ROE) | 4.41% | 13.52% | 14.03% | 26.27% | 19.81% |
| Return on Capital Employed (ROCE) | -5.21% | -11.57% | -11.29% | -10.75% | -8.45% |
| Return on Invested Capital (ROIC) | -4.26% | -9.13% | -8.52% | -8.85% | -7.88% |
| Return on Tangible Assets | -1.74% | -5.63% | -5.77% | -10.49% | -5.93% |
| Earnings Yield | -2361.38% | -5391.36% | -2504.75% | -2973.15% | -4435.67% |
| Efficiency Ratios | |||||
| Receivables Turnover | 10.45 | 7.50 | 7.31 | 3.62 | 1.27 |
| Payables Turnover | 3.64 | 2.32 | 4.75 | 4.26 | 5.29 |
| Inventory Turnover | 9.46 | 13.85 | 15.22 | 7.36 | 14.25 |
| Fixed Asset Turnover | 0.12 | 0.10 | 0.13 | 0.14 | 0.15 |
| Asset Turnover | 0.07 | 0.06 | 0.09 | 0.08 | 0.08 |
| Working Capital Turnover Ratio | -0.43 | -0.31 | -0.63 | -1.62 | -17.29 |
| Cash Conversion Cycle | -26.65 | -82.15 | -2.92 | 64.53 | 244.55 |
| Days of Sales Outstanding | 34.91 | 48.64 | 49.92 | 100.72 | 287.89 |
| Days of Inventory Outstanding | 38.60 | 26.36 | 23.98 | 49.58 | 25.62 |
| Days of Payables Outstanding | 100.16 | 157.15 | 76.82 | 85.77 | 68.96 |
| Operating Cycle | 73.51 | 75.00 | 73.90 | 150.30 | 313.51 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -1386.01 | -2731.79 | -1898.84 | -1488.28 | -7459.79 |
| Free Cash Flow Per Share | -2013.24 | -5553.45 | -2693.50 | -4124.09 | -23250.39 |
| Dividend Paid and CapEx Coverage Ratio | -2.21 | -0.97 | -2.39 | -0.56 | -0.47 |
| Capital Expenditure Coverage Ratio | -2.21 | -0.97 | -2.39 | -0.56 | -0.47 |
| Operating Cash Flow Coverage Ratio | -0.06 | -0.10 | -0.08 | -0.07 | -0.13 |
| Operating Cash Flow to Sales Ratio | -0.44 | -1.04 | -0.51 | -0.46 | -0.74 |
| Free Cash Flow Yield | -7458.79% | -14142.61% | -3300.09% | -3645.95% | -18301.34% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.04 | -0.02 | -0.04 | -0.03 | -0.02 |
| Price-to-Sales (P/S) Ratio | 0.01 | 0.01 | 0.02 | 0.03 | 0.01 |
| Price-to-Book (P/B) Ratio | -0.00 | -0.00 | -0.01 | -0.01 | -0.00 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.01 | -0.01 | -0.03 | -0.03 | -0.01 |
| Price-to-Operating Cash Flow Ratio | -0.02 | -0.01 | -0.04 | -0.08 | -0.02 |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 |
| Enterprise Value Multiple | -46.55 | -10.76 | -9.44 | -7.71 | -7.09 |
| Enterprise Value | 3.34B | 3.72B | 3.25B | 3.10B | 2.58B |
| EV to EBITDA | -46.55 | -10.76 | -9.44 | -7.71 | -7.09 |
| EV to Sales | 7.26 | 9.69 | 6.05 | 6.56 | 5.32 |
| EV to Free Cash Flow | -11.40 | -4.60 | -8.29 | -5.16 | -2.31 |
| EV to Operating Cash Flow | -16.55 | -9.35 | -11.75 | -14.30 | -7.18 |
| Tangible Book Value Per Share | 4418.39 | 2507.96 | 5826.05 | 4657.57 | 22569.78 |
| Shareholders’ Equity Per Share | -14442.91 | -15662.02 | -14573.80 | -12801.96 | -28445.31 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.02 | 0.03 | 0.04 | 0.08 | 0.01 |
| Revenue Per Share | 3162.53 | 2637.06 | 3690.95 | 3242.34 | 10082.35 |
| Net Income Per Share | -637.37 | -2117.05 | -2044.35 | -3363.06 | -5635.16 |
| Tax Burden | 0.25 | 0.46 | 0.54 | 0.58 | 0.51 |
| Interest Burden | 1.69 | 1.41 | 1.20 | 1.60 | 1.15 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.58 | 1.18 | 0.61 | 0.66 | 0.72 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | -0.01 | 0.03 |
| Income Quality | 0.53 | 0.61 | 0.93 | 0.44 | 1.32 |
Currency in CNY
